MedTrace Logo

Is Real-time CGM Superior to Flash Glucose Monitoring in Real Life Study (CORRIDA LIFE)

NCT04759495 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 187

Last updated 2021-02-18

No results posted yet for this study

Summary

The aim of the investigator's study is to compare real-time continuous glucose monitoring (rt-CGM) and flash glucose monitoring (FGM) in adult patients with Type 1 Diabetes (T1D) in real life practice during 24 weeks of follow-up.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DEVICE

Continuous Glucose Monitoring Dexcom G5 and G6 system (real-time continuous glucose monitoring)

rtCGM is used in Type 1 diabetic patients to improve glucose control and to minimize or avoid severe hypoglycaemia.

DEVICE

Continuous Glucose Monitoring FreeStyle Libre Flash system (flash glucose monitoring)

FGM is used in Type 1 diabetic patients to improve glucose control and to minimize or avoid severe hypoglycaemia.

Sponsors & Collaborators

  • Charles University, Czech Republic

    lead OTHER

Principal Investigators

  • Jan Soupal · Charles University, Prague

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-11-30
Completion
2021-09-30
FDA Device
Yes

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04759495 on ClinicalTrials.gov